Stocktoria
Maze Therapeutics, Inc. MAZE
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2025-01-31
Maze Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| CITADEL ADVISORS LLC | 874,876 | $26.1M | 1.77% |
| TWO SIGMA INVESTMENTS, LP | 192,952 | $5.8M | 0.39% |
| AQR CAPITAL MANAGEMENT LLC | 27,161 | $810,485 | 0.06% |
| D. E. Shaw & Co., Inc. | 12,019 | $358,647 | 0.02% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.